AHR, a novel inhibitory immune checkpoint receptor, is a potential therapeutic target for chemoresistant glioblastoma.
AHR 是一种新型的抑制性免疫检查点受体，是化疗耐药性胶质母细胞瘤的潜在治疗靶点
期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-023-04894-w
Tan Nian, Zhao Wei, Wang Yiyang, Li Ping, Liu Jianwei, Sun Zhaoying, Pan Jianming, Song Shilin, Li Shunyao, Liu Ziyi, Bian Yuhong
